TriangleTREATMENT READING
Aggressive B-Cell Non-Hodgkin Lymphoma
Choose a source section by treatment, subtype or setting. Patient and professional reading are labelled separately.
Selected text from the National Cancer Institute, with original links and dates. This Triangle reading page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
6 studies cited in this topic · see design and results →
Explore 5 related disease and treatment settings → · Source-derived catalogue; clinical review pending.
Late Effects of Treatment of NHL
Therapeutic approaches
Therapeutic approaches
Therapeutic approaches
Therapeutic options
Therapeutic options
Treatment Option Overview for Aggressive B-Cell Non-Hodgkin Lymphoma
Treatment of Aggressive Stage I and Aggressive, Contiguous Stage II B-Cell Non-Hodgkin Lymphoma
Stage IE or IIE Gastric DLBCL
Treatment Options for Aggressive Stage I and Aggressive, Contiguous Stage II B-Cell Non-Hodgkin Lymphoma
R-CHOP with or without IF-XRT
Treatment of Aggressive, Noncontiguous Stage II/III/IV B-Cell Non-Hodgkin Lymphoma
Treatment Options for Aggressive, Noncontiguous Stage II/III/IV B-Cell NHL
Pola-R-CHP
R-CHOP
Radiation therapy consolidation to sites of bulky disease
Bone marrow transplant (BMT) or stem cell transplant (SCT)
Prognostic factors
Treatment of Tumor Lysis Syndrome
Central Nervous System (CNS) Prophylaxis
Treatment of Aggressive, Recurrent B-Cell Non-Hodgkin Lymphoma
Treatment Options for Aggressive, Recurrent B-Cell Non-Hodgkin Lymphoma
CAR T-cell therapy for primary refractory disease or relapse within 1 year (or relapse after autologous SCT)
BMT or SCT consolidation
BMT
Peripheral SCT
CAR T-cell therapy for relapse after autologous SCT
Tafasitamab plus lenalidomide
Bispecific T-cell engagers
Epcoritamab
Glofitamab
Polatuzumab vedotin plus rituximab and bendamustine
Loncastuximab tesirine
Rituximab plus lenalidomide
Palliative radiation therapy
Treatment of B-Cell Lymphoblastic Lymphoma/B-Cell Acute Lymphoblastic Leukemia
Treatment of Diffuse Small Noncleaved-Cell/Burkitt Lymphoma
Treatment Options for Diffuse Small Noncleaved-Cell/Burkitt Lymphoma
Aggressive multidrug regimens
CNS prophylaxis
Preserved source evidence · Independent clinical review pending · Not medical advice